Effects of naturally occurring mutations in CUB-1 domain on synthesis, stability, and activity of ADAMTS-13.
暂无分享,去创建一个
Zhou Zhou | Renhao Li | Jing-Fei Dong | Hua Jing | Zhenyin Tao | Huiwan Choi | Khatira Aboulfatova | Joel Moake
[1] B. Hoppe,et al. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS). , 2004, Kidney international.
[2] K. Fujikawa,et al. Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura* , 2001, The Journal of Biological Chemistry.
[3] T. Foroud,et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura , 2001, Nature.
[4] J. Moake,et al. Platelet‐derived VWF‐cleaving metalloprotease ADAMTS‐13 , 2005, Journal of thrombosis and haemostasis : JTH.
[5] Y. Okada,et al. Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets. , 2004, Biochemical and biophysical research communications.
[6] B. Sachais,et al. The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow. , 2007, Blood.
[7] Kazuo Fujikawa,et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. , 2002, Blood.
[8] Sanjeev Gupta,et al. ADAMTS13 is expressed in hepatic stellate cells , 2005, Laboratory Investigation.
[9] J. Moake,et al. Human endothelial cells synthesize and release ADAMTS‐13 , 2006, Journal of thrombosis and haemostasis : JTH.
[10] L. P. Van den Heuvel,et al. Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency. , 2003, Kidney international.
[11] B. Lämmle,et al. Recovery and Half-Life of von Willebrand Factor-Cleaving Protease after Plasma Therapy in Patients with Thrombotic Thrombocytopenic Purpura , 1999, Thrombosis and Haemostasis.
[12] J. Sadler,et al. Binding of ADAMTS13 to von Willebrand Factor* , 2005, Journal of Biological Chemistry.
[13] J. Calvete,et al. The crystal structures of two spermadhesins reveal the CUB domain fold , 1997, Nature Structural Biology.
[14] A. Bernardo,et al. Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow. , 2005, Blood.
[15] X. Zheng,et al. Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts. , 2006, Blood.
[16] J. Voorberg,et al. Antibodies against the CUB1-2 domains of ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship. , 2007, Haematologica.
[17] Toshio Mori,et al. Localization of ADAMTS13 to the stellate cells of human liver. , 2005, Blood.
[18] J. Moake,et al. Novel ADAMTS‐13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura , 2006, Journal of thrombosis and haemostasis : JTH.
[19] J. Moake,et al. Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions. , 2005, Blood.
[20] X. Zheng,et al. Inhibitory autoantibodies against ADAMTS‐13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS‐13 protease and may accelerate its clearance in vivo , 2006, Journal of thrombosis and haemostasis : JTH.
[21] H. Tsai. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. , 1996, Blood.
[22] E. Bouhassira,et al. Enzymatically Active ADAMTS13 Variants Are Not Inhibited by Anti-ADAMTS13 Autoantibodies , 2005, Journal of Biological Chemistry.
[23] J. Pimanda,et al. Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13. , 2004, Blood.
[24] J. Sadler,et al. Cleavage of von Willebrand Factor Requires the Spacer Domain of the Metalloprotease ADAMTS13* , 2003, Journal of Biological Chemistry.